Skip to main content
SpringerLink
Log in

Galantamine/memantine

Weight loss (first report with memantine) in an elderly patient receiving dopamine receptor agonists: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Gallini A, Sommet A, Salandini A-M, Veyssière P, Montastruc J-L.Weight-loss associated with anti-dementia drugs in a patient with Parkinson’s disease. Movement Disorders 22: 1980-1981, No. 13, 15 Oct 2007 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galantamine/memantine. React. Wkly. 1179, 16 (2007). https://doi.org/10.2165/00128415-200711790-00047

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711790-00047

Keywords

Search

Navigation